Advertisement

OmniAb, Inc. OABI

Set alert

Price alert · OABI

All alert types
5.09 USD -0.02 -0.39%

At close · Nov 2

5.09 0.00 0.00%

After hours · Nov 2, 4:42 PM ET

Bid
5.08 × 2
Ask
5.09 × 2
4.94 Day range 5.31
1.30 52-week range 5.43
YTD
+175.14%
1 year
+228.39%
Open
5.11
Prev close
5.11
Mkt cap
742.43M
Vol
2.15M
Avg vol
1.71M
EPS
-0.34
P/E
0.00
Div yield
0.00%
More statistics
Low
4.94
High
5.31
Forward P/E
-8.95
Beta
0.44
Short ratio
14.24
Inst. own
68.95%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
4.00
200-d avg
4.38
1y target
9.63

5D chart

Chart tools
Interval

Signals (82)
NameTimeAgo
RSI: OverboughtOct 30, 3:55 PM3 days ago
SMA: BullishOct 30, 3:40 PM3 days ago
SMA: BearishOct 30, 3:35 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
MACD: Buy SignalOct 30, 2:45 PM3 days ago
MACD: Sell SignalOct 30, 2:40 PM3 days ago
MACD: Buy SignalOct 30, 2:35 PM3 days ago
SMA: BullishOct 30, 2:20 PM3 days ago
SMA: BearishOct 30, 1:40 PM3 days ago
MACD: Sell SignalOct 30, 1:40 PM3 days ago
SMA: BullishOct 30, 1:15 PM3 days ago
SMA: BearishOct 30, 12:05 PM3 days ago
SMA: BullishOct 30, 11:45 AM3 days ago
SMA: BearishOct 30, 11:40 AM3 days ago
SMA: BullishOct 30, 11:15 AM3 days ago
MACD: Buy SignalOct 30, 10:35 AM3 days ago
SMA: BullishOct 30, 10:25 AM3 days ago
RSI: OversoldOct 30, 10:05 AM3 days ago
RSI: OversoldOct 30, 9:45 AM3 days ago
SMA: BearishOct 30, 9:30 AM3 days ago
SMA: BearishOct 30, 9:30 AM3 days ago
MACD: Sell SignalOct 30, 9:30 AM3 days ago
RSI: OversoldOct 30, 9:30 AM3 days ago
SMA: BullishOct 29, 3:20 PM4 days ago
MACD: Buy SignalOct 29, 3:05 PM4 days ago
SMA: BullishOct 29, 3:00 PM4 days ago
MACD: Sell SignalOct 29, 1:10 PM4 days ago
SMA: BearishOct 29, 12:50 PM4 days ago
SMA: BearishOct 29, 12:50 PM4 days ago
SMA: BullishOct 29, 12:45 PM4 days ago
SMA: BearishOct 29, 12:30 PM4 days ago
MACD: Buy SignalOct 29, 12:25 PM4 days ago
SMA: BearishOct 29, 11:50 AM4 days ago
MACD: Sell SignalOct 29, 10:15 AM4 days ago
SMA: BearishOct 29, 10:05 AM4 days ago
RSI: OverboughtOct 28, 3:55 PM5 days ago
MACD: Buy SignalOct 28, 3:25 PM5 days ago
SMA: BullishOct 28, 3:20 PM5 days ago
SMA: BullishOct 28, 3:20 PM5 days ago
SMA: BearishOct 28, 3:00 PM5 days ago
SMA: BearishOct 28, 3:00 PM5 days ago
SMA: BullishOct 28, 2:40 PM5 days ago
MACD: Sell SignalOct 28, 2:10 PM5 days ago
SMA: BearishOct 28, 2:05 PM5 days ago
MACD: Buy SignalOct 28, 1:20 PM5 days ago
SMA: BullishOct 28, 12:30 PM5 days ago
SMA: BearishOct 28, 11:40 AM5 days ago
SMA: BearishOct 28, 11:05 AM5 days ago
MACD: Sell SignalOct 28, 11:05 AM5 days ago
SMA: BearishOct 28, 10:50 AM5 days ago
RSI: OverboughtOct 28, 10:15 AM5 days ago
MACD: Buy SignalOct 28, 9:40 AM5 days ago
RSI: OverboughtOct 28, 9:40 AM5 days ago
SMA: BullishOct 27, 3:50 PM6 days ago
SMA: BullishOct 27, 3:50 PM6 days ago
SMA: BearishOct 27, 3:20 PM6 days ago
MACD: Sell SignalOct 27, 3:20 PM6 days ago
MACD: Buy SignalOct 27, 2:50 PM6 days ago
SMA: BullishOct 27, 2:25 PM6 days ago
SMA: BearishOct 27, 2:20 PM6 days ago
SMA: BullishOct 27, 2:00 PM6 days ago
SMA: BearishOct 27, 1:50 PM6 days ago
SMA: BearishOct 27, 1:50 PM6 days ago
RSI: OverboughtOct 27, 1:30 PM6 days ago
RSI: OverboughtOct 27, 1:00 PM6 days ago
SMA: BullishOct 27, 12:45 PM6 days ago
RSI: OverboughtOct 27, 11:50 AM6 days ago
MACD: Sell SignalOct 27, 11:35 AM6 days ago
RSI: OverboughtOct 27, 11:20 AM6 days ago
RSI: OverboughtOct 27, 10:35 AM6 days ago
RSI: OverboughtOct 27, 9:35 AM6 days ago
MACD: Buy SignalOct 26, 3:55 PM1 week ago
SMA: BullishOct 26, 3:50 PM1 week ago
SMA: BearishOct 26, 3:15 PM1 week ago
MACD: Sell SignalOct 26, 3:10 PM1 week ago
SMA: BullishOct 26, 2:10 PM1 week ago
MACD: Buy SignalOct 26, 1:30 PM1 week ago
MACD: Sell SignalOct 26, 12:35 PM1 week ago
SMA: BearishOct 26, 12:30 PM1 week ago
SMA: BearishOct 26, 12:30 PM1 week ago
SMA: BullishOct 26, 11:00 AM1 week ago
SMA: BearishOct 26, 10:20 AM1 week ago

Key statistics

Market cap
422.34M
Enterprise value
388.00M
Trailing P/E
0.00
Forward P/E
-8.95
PEG ratio
0.00
Price / sales
20.69
Price / book
1.44
EPS (TTM)
-0.62
Beta
0.44
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
20.41M
Revenue growth
-23.80%
Free cash flow
-13.94M
Total cash
59.38M
Total debt
23.84M
Return on equity
-20.45%
Shares outstanding
121.01M
Short % of float
7.00%
50-day average
4.00
200-day average
4.38

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 9.63 +89.1% upside
Target (low)
7.00
Target (mean)
9.63
Target (high)
12.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy6
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Aug 8, 2024

Expected Aug 8, 2024. Consensus EPS estimate -0.09667.

Earnings history

Financials — quick view

All financials
OABI Revenue — quarterly 3.99M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
OABI Net income — quarterly -15.73M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
OABI EPS — quarterly -0.12
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

OABI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2024Sep 1, 2024-0.14-0.16-0.02-14.29%
Aug 8, 2024Jun 1, 2024-0.18-0.13+0.05+27.78%
Aug 8, 2024Jun 1, 2024-0.18———
May 9, 2024Mar 1, 2024-0.17-0.19-0.02-11.76%
May 9, 2024Mar 1, 2024-0.17———
Mar 20, 2024Dec 1, 2023-0.17———

Upgrades / downgrades

OABI analyst upgrades and downgrades
DateFirmActionFromTo
Nov 14, 2024BenchmarkreitBuyBuy
Nov 14, 2024HC Wainwright & Co.reitBuyBuy
Aug 19, 2024BenchmarkreitBuyBuy
Aug 16, 2024RBC CapitalreitOutperformOutperform
Aug 12, 2024HC Wainwright & Co.reitBuyBuy
May 14, 2024BenchmarkreitBuyBuy

About OmniAb, Inc.

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
omniab.com

News

Your note

Sign in to keep a note on OABI — it syncs with the Stock Master app.

Insider holders

OABI insider holders
InsiderRelationLatest transactionDateShares held
AVISTA CAPITAL MANAGING MEMBER V, LLCBeneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityJun 27, 20240
BERKMAN CHARLES SOfficerSaleDec 8, 2024323,385
BERTOZZI CAROLYN RDirectorConversion of Exercise of derivative securityOct 31, 202455,539
BOYCE SARAHDirectorConversion of Exercise of derivative securityJun 17, 202468,381
COCHRAN JENNIFER R.DirectorConversion of Exercise of derivative securityJul 11, 2024115,274
FOEHR MATTHEW WChief Executive OfficerSaleDec 8, 20243,714,450

Institution ownership

OABI institution ownership
Holder% heldSharesValueReported
Avista Capital Holdings, L.P. 13.07%15,817,93455.20MSep 29, 2024
Janus Henderson Group PLC6.50%7,871,32827.47MSep 29, 2024
Blackrock Inc.5.97%7,223,54925.21MSep 29, 2024
Vanguard Group Inc4.29%5,191,68518.12MSep 29, 2024
Macquarie Group Limited3.57%4,323,10015.09MSep 29, 2024
Chicago Capital, LLC2.61%3,162,55511.04MSep 29, 2024

Fund ownership

OABI fund ownership
Holder% heldSharesValueReported
Janus Henderson Triton Fund4.07%4,923,67817.18MSep 29, 2024
Delaware Group Equity Fds V-Small Cap Core Fund2.38%2,879,89210.05MAug 30, 2024
Vanguard Total Stock Market Index Fund2.14%2,594,4649.05MSep 29, 2024
iShares Russell 2000 ETF1.90%2,299,4758.03MOct 30, 2024
Janus Henderson Venture Fund1.78%2,159,9607.54MSep 29, 2024
Vanguard Extended Market Index Fund1.29%1,555,6575.43MSep 29, 2024
Advertisement